Drug Interactions between Cipro and Vibramycin
This report displays the potential drug interactions for the following 2 drugs:
- Cipro (ciprofloxacin)
- Vibramycin (doxycycline)
Interactions between your drugs
No interactions were found between Cipro and Vibramycin. This does not necessarily mean no interactions exist. Always consult your healthcare provider.
Cipro
A total of 591 drugs are known to interact with Cipro.
- Cipro is in the drug class quinolones.
-
Cipro is used to treat the following conditions:
- Anthrax
- Anthrax Prophylaxis
- Bacteremia
- Bacterial Infection
- Bladder Infection
- Bone infection
- Bronchiectasis
- Bronchitis
- Chancroid
- Cholera
- Cutaneous Bacillus anthracis
- Diverticulitis
- Epididymitis, Sexually Transmitted
- Febrile Neutropenia
- Gonococcal Infection, Disseminated
- Gonococcal Infection, Uncomplicated
- Granuloma Inguinale
- Infection Prophylaxis
- Infectious Diarrhea
- Intraabdominal Infection
- Joint Infection
- Kidney Infections
- Meningococcal Meningitis Prophylaxis
- Mycobacterium avium-intracellulare, Treatment
- Nosocomial Pneumonia
- Peritonitis
- Plague
- Plague Prophylaxis
- Pneumonia
- Pneumonia with Cystic Fibrosis
- Prostatitis
- Rabbit Fever
- Salmonella Enteric Fever
- Salmonella Gastroenteritis
- Shigellosis
- Sinusitis
- Skin and Structure Infection
- Skin or Soft Tissue Infection
- Surgical Prophylaxis
- Traveler's Diarrhea
- Tuberculosis, Active
- Typhoid Fever
- Urinary Tract Infection
Vibramycin
A total of 189 drugs are known to interact with Vibramycin.
- Vibramycin is in the following drug classes: miscellaneous antimalarials, tetracyclines.
-
Vibramycin is used to treat the following conditions:
- Acne
- Actinomycosis
- Amebiasis
- Anthrax
- Anthrax Prophylaxis
- Bacterial Infection
- Bartonellosis
- Bronchiectasis
- Bronchitis
- Brucellosis
- Bullous Pemphigoid
- Cervicitis
- Chancroid
- Chlamydia Infection
- Cholera
- Cutaneous Bacillus anthracis
- Ehrlichiosis
- Enterocolitis
- Epididymitis, Sexually Transmitted
- Gastroenteritis
- Gonococcal Infection, Uncomplicated
- Granuloma Inguinale
- Lyme Disease
- Lyme Disease, Arthritis
- Lyme Disease, Carditis
- Lyme Disease, Erythema Chronicum Migrans
- Lyme Disease, Neurologic
- Lymphogranuloma Venereum
- Malaria
- Malaria Prevention
- Melioidosis
- Mycoplasma Pneumonia
- Nongonococcal Urethritis
- Ocular Rosacea
- Pelvic Inflammatory Disease
- Pemphigoid
- Pemphigus
- Periodontitis
- Plague
- Pleural Effusion
- Pneumonia
- Proctitis
- Prostatitis
- Psittacosis
- Rabbit Fever
- Rickettsial Infection
- Rosacea
- Skin or Soft Tissue Infection
- STD Prophylaxis
- Syphilis, Early
- Syphilis, Latent
- Tertiary Syphilis
- Trachoma
- Upper Respiratory Tract Infection
- Urinary Tract Infection
Drug and food interactions
ciprofloxacin food
Applies to: Cipro (ciprofloxacin)
Do not take ciprofloxacin with dairy products such as milk or yogurt, or with calcium-fortified foods (e.G., cereal, juice). You may eat or drink dairy products or calcium-fortified foods with a regular meal, but do not use them alone when taking ciprofloxacin. They could make the medication less effective. When ciprofloxacin tablets are given with enteral (tube) feedings, ciprofloxacin may not work as well. You could interrupt the feeding for 1 hour before and 2 hours after the ciprofloxacin dose, or your doctor may decide to switch to a different treatment. Ciprofloxacin oral suspension should not be given via nasogastric tubes or feeding tubes. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See Also
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.